Monday, April 29, 2024

Rare heart inflammation from COVID-19 vaccination currently being investigated

Share

Young men are being warned of a rare heart inflammation that occurs for up to two weeks after receiving a second dose of an mRNA COVID-19 vaccine.

BCCDC confirmed that heart inflammation has been verified and is reported to occur mainly in men under 30 after the second dose of COVID-19 mRNA vaccine.

While cases are rare, some people are experiencing conditions known as myocarditis or pericarditis of up to two weeks following immunization.

On their website, the BCCDC reported that the condition has appeared to be only mild or moderate, with people recovering fully with treatment and rest.

At this time, the BCCDC are saying that the condition is being investigated, and that this is only an association between vaccination and this condition. There is no conclusion on the exact cause of those cases.

While side effects are not uncommon with COVID-19 vaccines, including dizziness, nausea, and a fever, serious side effects appear to be much more uncommon, though they have occurred.

A link between thrombosis which causes blood clots and the AstraZeneca vaccine have affected between four and six people in every million after being vaccinated.

For those with anaphylaxis, a serious allergic reaction may occur due to Polyethylene glycol (PEG) an ingredient in both the Moderna and Pfizer mRNA vaccines and Polysorbate 80 an ingredient found in the AstraZeneca vaccines.

For more information, visit the vaccine safety page.

Read more

Latest Stories